BIO-key International (NASDAQ:BKYI), Inc. is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.
In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems. Its solutions support use cases in healthcare, financial services, education, retail and public sector agencies, where reliable and auditable authentication is required. BIO-key also offers cloud-based multi-factor authentication services, enabling remote and hybrid workforces to access critical applications securely.
Headquartered in Wall Township, New Jersey, BIO-key maintains a presence in North America as well as partnerships in Europe and Asia to distribute its biometric products and services internationally. The company emphasizes ongoing research and development in biometric algorithms, user interface design and mobile integration in order to respond to evolving cybersecurity threats.
The executive leadership team is led by Chief Executive Officer Mike DePasquale, who brings experience in identity management and software commercialization. Under this leadership, BIO-key continues to pursue partnerships, channel expansions and product enhancements aimed at broadening the adoption of fingerprint authentication across industry verticals.
